Magneto-Erythrocyte Membrane Vesicles’ Superior T2 MRI Contrast Agents to Magneto-Liposomes 

Nina Kostevšek*, Patricija Miklavc, Matic Kisovec, Marjetka Podobnik, Wafa Al-Jamal, Igor Serša

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
4 Downloads (Pure)

Abstract

Despite their high potential, most of the clinically approved iron oxide (IO)-based contrast agents for magnetic resonance imaging (MRI) have been withdrawn from the market either due to safety issues or lack of sales. To address this challenge, erythrocyte membranes have been used to prepare IO-based T2 contrast agents with superior MRI properties and higher safety margin. A simple formulation procedure has been proposed, and the nanostructures’ morphology and physicochemical properties have been evaluated. We compared their performance in terms of contrast ability in MRI to the more clinically established magneto-liposomes and non-encapsulated nanoparticles (NPs). The encapsulation of 5-nm iron oxide nanoparticles (IO NPs) in the liposomes and erythrocyte membrane vesicles (EMVs) led to a significant improvement in their r2 relaxivity. r2 values increased to r2 = 188 ± 2 mM−1s−1 for magneto-liposomes and r2 = 269 ± 3 mM−1s−1 for magneto-erythrocyte membranes, compared to “free” IO NPs with (r2 = 12 ± 1 mM−1 s−1), measured at a 9.4 T MRI scanner. The superiority of magneto-erythrocyte membranes in terms of MRI contrast efficacy is clearly shown on T2-weighted MR images. Our study revealed the hemocompatibility of the developed contrast agents in the MRI-relevant concentration range.

Original languageEnglish
Article number51
Number of pages14
JournalMagnetochemistry
Volume7
Issue number4
Early online date11 Apr 2021
DOIs
Publication statusPublished - 11 Apr 2021

Bibliographical note

Funding Information:
Funding: The study was supported by the Slovenian Research Agency ARRS (project numbers Z2-9218, P2-0084, P1-0060 and P1-0391) and the Engineering and Physical Sciences Research Council (EPSRC) (EP/M008657/1).

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.

Keywords

  • Contrast agents
  • Erythrocyte membranes
  • Iron oxide nanoparticles
  • Liposomes
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Chemistry (miscellaneous)
  • Materials Chemistry
  • Electronic, Optical and Magnetic Materials

Fingerprint

Dive into the research topics of 'Magneto-Erythrocyte Membrane Vesicles’ Superior T2 MRI Contrast Agents to Magneto-Liposomes '. Together they form a unique fingerprint.

Cite this